Article
Centrosome amplification primes for apoptosis and favors the response to chemotherapy in…
medRxiv · 2023 · Edwards, F.; Fantozzi, G.; Simon, A. Y.; Morretton, J.-P.; Herbette, A.; Tijhuis, A. E.; Wardenaar, R.; Foulane, S.; Gemble, S.; Spierings, D. C. J.; Foijer, F.; Mariani, O.; Vincent-Salomon, A.; Roman-Roman, S.; Sastre-Garau, X.; Goundiam, O.; Basto, R.
Key facts
| Title | Centrosome amplification primes for apoptosis and favors the response to chemotherapy in ovarian cancer beyond multipolar divisions |
|---|---|
| First author | Edwards, F.; Fantozzi, G.; Simon, A. Y.; Morretton, J.-P.; Herbette, A.; Tijhuis, A. E.; Wardenaar, R.; Foulane, S.; Gemble, S.; Spierings, D. C. J.; Foijer, F.; Mariani, O.; Vincent-Salomon, A.; Roman-Roman, S.; Sastre-Garau, X.; Goundiam, O.; Basto, R. |
| Journal | medRxiv |
| Published | Aug 7, 2023 |
| DOI | 10.1101/2023.07.28.550973 |
| Devices mentioned | K952425, K952466 |
| Product codes mentioned | HWE, JHN, JIX, JJH, MVU, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1